美国国家骨骼健康联盟(NBHA)新骨质疏松诊断标准对美国骨质疏松患病率的影响:补充说明
该补充说明评估了采用NBHA骨质疏松诊断标准(在骨密度基础上纳入特定骨折和FRAX评分)后的骨质疏松患病率,指出扩展定义较单纯骨密度定义提高了患病率,但可能更好地识别骨折风险升高人群,该标准已获NOF、ASBMR等机构认可。
要点
- NBHA扩展诊断标准在骨密度T值≤-2.5基础上纳入髋部骨折、特定部位脆性骨折及FRAX评分达标。
- 扩展定义较单纯骨密度定义提高了骨质疏松患病率。
- 扩展定义可能更好地识别骨折风险升高人群。
核心结论
- 与单纯骨密度定义相比,NBHA扩展定义提高了骨质疏松患病率,但可能更好地识别骨折风险升高人群。
研究设计与样本
- 补充说明性文章,评估美国绝经后女性和50岁以上男性中采用NBHA骨质疏松诊断标准的患病率。
主要发现
- 扩展定义较单纯骨密度定义提高了骨质疏松患病率。
- 扩展定义可能更好地识别骨折风险升高人群。
关键数值与推荐
- 新诊断标准继续包括DXA测定的脊柱或髋部T值≤-2.5。
- 新诊断标准另包括髋部骨折(伴或不伴骨密度检测)。
- 新诊断标准另包括低骨量者的椎体、骨盆、肱骨近端以及部分病例的桡骨远端骨折。
- 新诊断标准另包括FRAX评分达到或超过NOF指南的骨质疏松治疗切点。
临床怎么用
- NBHA工作组的建议已获NOF、ASBMR及多个专业医学团体认可,并出现在NOF临床医师指南中。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We evaluated the prevalence of osteoporosis using the osteoporosis diagnostic criteria developed by the National Bone Health Alliance (NBHA), which includes qualified fractures, FRAX score in addition to BMD. The expanded definition increases the prevalence compared to BMD alone definitions; however, it may better identify those at elevated fracture risk. Recently an NBHA working Group published a paper in OI with recommendations for expanding the criteria that would constitute an osteoporosis diagnosis in postmenopausal women and in men over age 50 for use in the US - Siris et al., Osteoporosis International 25(%): 1439-1443, 2014. The recommendations have now been endorsed by NOF, ASBMR and a number of professional medical groups and appear in the NOF Clinician's Guide. The new diagnostic criteria continue to include a T-score by DXA of spine or hip that is less than or equal to -2.5, but alternatively also include a hip fracture with or without BMD testing or a vertebral, pelvis, proximal humerus and in some cases a distal forearm fracture in a person with low bone mass, or a FRAX score that meets or exceeds the NOF Guide osteoporosis treatment cut point.
引用
- Wright NC, Saag KG, Dawson-Hughes B, et al. The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the United States: supplementary presentation. Osteoporos Int. 2017. PMID: 28936598. doi:10.1007/s00198-017-4207-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。